These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 24637544

  • 1. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
    Shah M, Ssengooba W, Armstrong D, Nakiyingi L, Holshouser M, Ellner JJ, Joloba M, Manabe YC, Dorman SE.
    AIDS; 2014 Jun 01; 28(9):1307-14. PubMed ID: 24637544
    [Abstract] [Full Text] [Related]

  • 2. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, Steingart KR.
    Cochrane Database Syst Rev; 2016 May 10; 2016(5):CD011420. PubMed ID: 27163343
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.
    Shah M, Dowdy D, Joloba M, Ssengooba W, Manabe YC, Ellner J, Dorman SE.
    AIDS; 2013 Nov 28; 27(18):2883-92. PubMed ID: 25119690
    [Abstract] [Full Text] [Related]

  • 4. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J, Theron G, Chanda D, Clowes P, Rachow A, Lesosky M, Hoelscher M, Mwaba P, Pym A, Dheda K, TB-NEAT team.
    BMC Infect Dis; 2015 Jul 09; 15():262. PubMed ID: 26156025
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
    Lawn SD, Kerkhoff AD, Burton R, Schutz C, Boulle A, Vogt M, Gupta-Wright A, Nicol MP, Meintjes G.
    BMC Med; 2017 Mar 21; 15(1):67. PubMed ID: 28320384
    [Abstract] [Full Text] [Related]

  • 6. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH, Griesel R, Stewart A, Mendelson M, Maartens G.
    Int J Infect Dis; 2018 Oct 21; 75():67-73. PubMed ID: 30125689
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
    Lawn SD, Kerkhoff AD, Vogt M, Wood R.
    Lancet Infect Dis; 2012 Mar 21; 12(3):201-9. PubMed ID: 22015305
    [Abstract] [Full Text] [Related]

  • 8. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE, Mayanja-Kizza H, Manabe YC.
    PLoS One; 2015 Mar 21; 10(7):e0133756. PubMed ID: 26222142
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis.
    Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Broger T, Denkinger CM, Rangaka MX, Gupta-Wright A, Fielding K, Wood R, Huerga H, Rücker SCM, Bjerrum S, Johansen IS, Thit SS, Kyi MM, Hanson J, Barr DA, Meintjes G, Maartens G.
    J Infect; 2022 Jul 21; 85(1):40-48. PubMed ID: 35588942
    [Abstract] [Full Text] [Related]

  • 10. Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children.
    LaCourse SM, Pavlinac PB, Cranmer LM, Njuguna IN, Mugo C, Gatimu J, Stern J, Walson JL, Maleche-Obimbo E, Oyugi J, Wamalwa D, John-Stewart G.
    AIDS; 2018 Jan 02; 32(1):69-78. PubMed ID: 29028662
    [Abstract] [Full Text] [Related]

  • 11. An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag.
    Esmail A, Pooran A, Sabur NF, Fadul M, Brar MS, Oelofse S, Tomasicchio M, Dheda K.
    J Clin Microbiol; 2020 Sep 22; 58(10):. PubMed ID: 32727831
    [Abstract] [Full Text] [Related]

  • 12. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
    Peter JG, Theron G, Muchinga TE, Govender U, Dheda K.
    PLoS One; 2012 Sep 22; 7(7):e39966. PubMed ID: 22815718
    [Abstract] [Full Text] [Related]

  • 13. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.
    Siddiqi OK, Birbeck GL, Ghebremichael M, Mubanga E, Love S, Buback C, Kosloff B, Ayles H, Atadzhanov M, Dheda K, Koralnik IJ.
    J Clin Microbiol; 2019 Aug 22; 57(8):. PubMed ID: 31189584
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
    Yakhelef N, Audibert M, Ferlazzo G, Sitienei J, Wanjala S, Varaine F, Bonnet M, Huerga H.
    PLoS One; 2020 Aug 22; 15(1):e0227138. PubMed ID: 31999746
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of Lipoarabinomannan and Xpert MTB/RIF Testing in Cerebrospinal Fluid To Diagnose Tuberculous Meningitis in an Autopsy Cohort of HIV-Infected Adults.
    Cox JA, Lukande RL, Kalungi S, Van Marck E, Lammens M, Van de Vijver K, Kambugu A, Nelson AM, Colebunders R, Manabe YC.
    J Clin Microbiol; 2015 Aug 22; 53(8):2667-73. PubMed ID: 26063865
    [Abstract] [Full Text] [Related]

  • 16. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
    Gina P, Randall PJ, Muchinga TE, Pooran A, Meldau R, Peter JG, Dheda K.
    BMC Infect Dis; 2017 May 12; 17(1):339. PubMed ID: 28499418
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H, Mathabire Rucker SC, Cossa L, Bastard M, Amoros I, Manhiça I, Mbendera K, Telnov A, Szumilin E, Sanchez-Padilla E, Molfino L.
    PLoS Med; 2019 Apr 12; 16(4):e1002792. PubMed ID: 31039161
    [Abstract] [Full Text] [Related]

  • 18. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT, Sturegård E, Winqvist N, Skogmar S, Reepalu A, Jemal ZH, Tibesso G, Schön T, Björkman P.
    PLoS One; 2014 Apr 12; 9(1):e85478. PubMed ID: 24465572
    [Abstract] [Full Text] [Related]

  • 19. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S, Triulzi I, Ciccacci F, Palla I, Palombi L, Marazzi MC, Giuliano M, Floridia M, Mancinelli S, Mutemba E, Turchetti G.
    PLoS One; 2018 Apr 12; 13(7):e0200523. PubMed ID: 30024890
    [Abstract] [Full Text] [Related]

  • 20. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.
    Nathavitharana RR, Lederer P, Chaplin M, Bjerrum S, Steingart KR, Shah M.
    Cochrane Database Syst Rev; 2021 Aug 20; 8(8):CD014641. PubMed ID: 34416013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.